NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/12/2024
Back to search
Official data from USPTO
AKOUOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
03/12/2024
Trademark type
Word
Nice classes
5
Filing date
11/20/2020
Registration date
03/12/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/12/2024
Last transaction
03/12/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/22/2023
First use in commerce
11/22/2023
Drawing code
4
Owner type
03
Owner location
Boston, MA, US
Examiner
YONTEF, DAVID ERIC
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Akouos, Inc.
Representatives
Bruce W. Longbottom
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biologics and small molecules both in the nature of pharmaceutical preparations for the treatment of genetically-related inner ear diseases and conditions causing hearing loss; gene therapy products to restoreimprove and preserve hearinggenetically engineered tissues for inner ear transplant purposes and drug delivery agents for use in the inner ear consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; gene therapy productsbiological preparations for the treatment of inner ear disorders and conditions; viral vectorsnon-viral vectors and gene therapy vectors all for medical purposestherapeutic agents for delivering nucleic acid and other genetic material to nuclei of targeted cells in the human bodyfor use in gene therapy to treat inner ear disorders and conditions; biotechnological platform technology for gene delivery to biological cellsbiological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapyall to restoreimprove and preserve hearing; biotechnological platform technology for gene delivery to biological cellsbiological nanoparticles and adenoviruses featuring adeno-associated viral (AAV) vectors therein to provide platforms for specific expressions of biologics with therapeutic effects in gene therapyall to treat inner ear disorders and conditions
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/03/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/02/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/01/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/01/2024
IUAF
USE AMENDMENT FILED
01/11/2024
EISU
TEAS STATEMENT OF USE RECEIVED
01/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/13/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/13/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/13/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/13/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/13/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/03/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2023
EX4G
SOU EXTENSION 4 GRANTED
08/02/2023
EXT4
SOU EXTENSION 4 FILED
08/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/02/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/09/2023
EX3G
SOU EXTENSION 3 GRANTED
02/07/2023
EXT3
SOU EXTENSION 3 FILED
02/07/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/07/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/11/2022
EX2G
SOU EXTENSION 2 GRANTED
08/09/2022
EXT2
SOU EXTENSION 2 FILED
08/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
08/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/10/2022
EX1G
SOU EXTENSION 1 GRANTED
02/08/2022
EXT1
SOU EXTENSION 1 FILED
02/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/08/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/15/2021
PUBO
PUBLISHED FOR OPPOSITION
06/15/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/26/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
05/11/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/11/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
05/11/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/11/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/11/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/07/2021
DOCK
ASSIGNED TO EXAMINER
05/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/26/2021
NWAP
NEW APPLICATION ENTERED
11/24/2020
Continuous trademark protection
Get notified about every new filing that threatens AKOUOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.